Symphony Capital is a private equity firm dedicated to investing in leading innovative biopharmaceutical companies, helping them capture more of the value in their most important clinical development programs.Based in New York, Symphony’s unique investment strategy brings a combination of dedicated capital, deep industry expertise and tailored investment structures to biopharmaceutical companies in the US, at all stages of clinical development.
Venture Capital
1 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.